Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management
European Journal of Pharmaceutics and Biopharmaceutics · 2025
DOI: 10.1016/j.ejpb.2025.114692 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmaceutics and Biopharmaceutics, 2025. Verfasst von Mariam Zewail und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Damanhour University, Damanhour, Egypt. Electronic address: mariamzewail@pharm.dmu.edu.eg. Hauptthemen laut MEDLINE: Psoriasis, Crotonates, Toluidines, Drug Delivery Systems. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 60 Literaturangaben.
Abstract (Originalsprache)
Conventional topical psoriasis treatments suffer from limited delivery to affected areas along with skin irritation due to high local drug concentration. Herein an attempt to improve the delivery of leflunomide's active metabolite (teriflunomide (TER)) by improving its solubility through nanoencapsulation in emulsomes (EMLs) besides ensuring effective intradermal delivery using hollow microneedles. Evaluation of colloidal characteristics of EMLs, encapsulation efficiency and drug release were performed. Additionally, the antipsoriatic activity in an imiquimod-induced psoriatic mouse model was evaluated by the measurement of inflammatory mediators' levels and histopathological assessment of anatomized skin. The particle size of the chosen EMLs formulation was 147.9 nm and the zeta potential value was -21.7. Entrapment efficiency was 97.23 % and EMLs provided sustained drug release for 48 h. No statistically significant differences in the in vivo levels of NF-KB, IL 8, MMP1, GSH, SOD and catalase between the animals treated by TER-EMLs and the negative control cohort were observed. Also, histopathological inspection of dissected skin samples reflected the superiority of TER-EMLs over TER suspension. Collectively, combining nanoencapsulation and hollow microneedles application improved TER properties and ensured effective TER delivery to the affected psoriatic areas.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutics, Damanhour University, Damanhour, Egypt. Electronic address: mariamzewail@pharm.dmu.edu.eg.
- Department of Pharmaceutics, Damanhour University, Damanhour, Egypt.
- Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutics, Damanhour University, Damanhour, Egypt; Postdoc Brigham and Women's Hospital, Harvard Medical School, Harvard University, United States.
Zitieren
APA
Zewail, M., Abbas, H., Sayed, N. E., & Abd-El-Azim, H. (2025). Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. European Journal of Pharmaceutics and Biopharmaceutics. https://doi.org/10.1016/j.ejpb.2025.114692
Vancouver
Zewail M, Abbas H, Sayed NE, Abd-El-Azim H. Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management. European Journal of Pharmaceutics and Biopharmaceutics. 2025. doi:10.1016/j.ejpb.2025.114692
BibTeX
@article{Zewail2025,
author = {Zewail, Mariam and Abbas, Haidy and Sayed, Nesrine El and Abd-El-Azim, Heba},
title = {Intradermal delivery of teriflunomide loaded emulsomes using hollow microneedles for effective minimally invasive psoriasis management},
journal = {European Journal of Pharmaceutics and Biopharmaceutics},
year = {2025},
doi = {10.1016/j.ejpb.2025.114692}
}
EUVIMED